Mink Therapeutics

Developer of T cell therapies for cancer and other immune-mediated diseases

placeNew York City, New York, United States calendar_todayFounded 2017 groups37 employees language minktherapeutics.com

Registered entities

Innovation

11 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 93 times.

YearFilings
20191
20232
20247
20259
20262

Social engagement

Social engagement: 7.2K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

28 May 2026
Milestone
regulatory
3 Apr 2026
Event
AACR2026 poster presentation
2 Apr 2026
Event
American Society of Gene and Cell Therapy (#ASGCT26) Annual Meeting
Coming soon